+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Impact of statin use on lipid levels in statin-naive patients with rheumatoid arthritis versus non-rheumatoid arthritis subjects: results from a population-based study



Impact of statin use on lipid levels in statin-naive patients with rheumatoid arthritis versus non-rheumatoid arthritis subjects: results from a population-based study



Arthritis Care and Research 65(10): 1592-1599



To examine lipid profiles among statin-naive patients with rheumatoid arthritis (RA) and those without RA before and after the initiation of statins. Information regarding lipid measures and statin use was gathered in a population-based incident cohort of patients with RA (1987 American College of Rheumatology criteria first met between January 1, 1988 and January 1, 2008) and in a cohort of non-RA subjects from the same underlying population. Only patients with no prior history of statin use were included. The study included 161 patients with RA (mean age 56.3 years, 57% female) and 221 non-RA subjects (mean age 56.0 years, 66% female). Prior to the start of statins, the levels of total cholesterol and low-density lipoprotein (LDL) cholesterol were lower in the RA versus the non-RA cohort (P < 0.001 and P = 0.003, respectively). The absolute and percentage change in LDL cholesterol after at least 90 days of statin use tended to be smaller in the RA versus the non-RA cohort (P = 0.03 and P = 0.09, respectively). After at least 90 days of statin use, patients with RA were less likely to achieve therapeutic goals for LDL cholesterol than the non-RA subjects (P = 0.046). Increased erythrocyte sedimentation rate (ESR) at baseline (odds ratio 0.47, 95% confidence interval 0.26-0.85) was associated with lower likelihood of achieving therapeutic LDL goals. Patients with RA had lower total cholesterol and LDL cholesterol levels before statin initiation and lower likelihood of achieving therapeutic LDL goals following statin use than the non-RA subjects. Some RA disease characteristics, in particular ESR at baseline, may have an adverse impact on achieving therapeutic LDL goals.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 053724570

Download citation: RISBibTeXText

PMID: 23592565

DOI: 10.1002/acr.22029


Related references

The impact of statin use on lipid levels in statin-naive patients with rheumatoid arthritis RA vs non-RA subjects Results from a population-based study. Arthritis Care & Research, 2013

Impact of statin discontinuation on mortality in patients with rheumatoid arthritis: a population-based study. Arthritis Care and Research 64(6): 809-816, 2012

Statin discontinuation and risk of acute myocardial infarction in patients with rheumatoid arthritis: a population-based cohort study. Annals of the Rheumatic Diseases 70(6): 1020-1024, 2011

Content validity of the Dutch Rheumatoid Arthritis Impact of Disease (RAID) score: results of focus group discussions in established rheumatoid arthritis patients and comparison with the International Classification of Functioning, Disability and Health core set for rheumatoid arthritis. Arthritis Research and Therapy 18: 22, 2016

Statin use and mortality in rheumatoid arthritis: a general population-based cohort study. Annals of the Rheumatic Diseases 75(7): 1315-1320, 2017

Clinical decision rules in rheumatoid arthritis: Do they identify patients at high risk for osteoporosis? Testing clinical criteria in a population based cohort of patients with rheumatoid arthritis recruited from the Oslo Rheumatoid Arthritis Register. Annals of the Rheumatic Diseases 61(12): 1085-1089, 2002

Validity of the rheumatoid arthritis impact of disease (RAID) score and definition of cut-off points for disease activity states in a population-based European cohort of patients with rheumatoid arthritis. Joint, Bone, Spine 85(3): 317-322, 2017

Association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non-rheumatoid arthritis patients. Arthritis and Rheumatology 67(8): 2004-2010, 2015

No increased occurrence of ischemic heart disease prior to the onset of rheumatoid arthritis: results from two Swedish population-based rheumatoid arthritis cohorts. Arthritis and Rheumatism 60(10): 2861-2869, 2009

Rheumatoid arthritis susceptibility genes associate with lipid levels in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases 70(6): 1025-1032, 2011

OP0182The Impact of Statin Use on Structural Bone Damage in Rheumatoid Arthritis. Annals of the Rheumatic Diseases 74(Suppl 2): 140.2-140, 2015

Should patients with rheumatoid arthritis receive statin therapy?. Arthritis and Rheumatism 60(5): 1205-1209, 2009

Psychometric properties and cross-language equivalence of the revised Bristol Rheumatoid Arthritis Fatigue and the Rheumatoid Arthritis Impact of Disease scales in rheumatoid arthritis. Quality of Life Research 2019, 2019

Treatment with leflunomide slows radiographic progression of rheumatoid arthritis: results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Leflunomide Rheumatoid Arthritis Investigators Group. Arthritis and Rheumatism 43(3): 495-505, 2000

Effect of high-intensity statin treatment in rheumatoid arthritis: a case with possible coronary atheroma regression and progression of rheumatoid valve degeneration. BMJ Case Reports 2009, 2009